Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise +2,708 $13.09 $35K 25,856
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise +1,000 $19.50 $20K 26,856
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise +958 $22.00 $21K 27,814
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise +471 $35.80 $17K 28,285
2020-02-05 Simpson Curran SVP, Product Development & CTO Sale −5,637 $50.00 $282K 22,648
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −471 39,979
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −958 21,561
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −1,000 12,378
2020-02-05 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −2,708 0
2020-02-05 Vasista Vittal Chief Financial Officer Sale −300 $50.00 $15K 222,021
2020-02-05 HAYDEN DONALD J JR Director Option exercise +2,000 $0.85 $2K 2,000
2020-02-05 HAYDEN DONALD J JR Director Sale −2,000 $50.00 $100K 0
2020-02-05 HAYDEN DONALD J JR Director Option exercise · Stock Option (Right to Buy) −2,000 153,900
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise +1,622 $19.50 $32K 25,570
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise +2,700 $22.00 $59K 28,270
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise +800 $35.80 $29K 29,070
2020-01-17 Simpson Curran SVP, Product Development & CTO Sale −5,922 $50.00 $296K 23,148
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −800 40,450
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −2,700 22,519
2020-01-17 Simpson Curran SVP, Product Development & CTO Option exercise · Stock Option (Right to Buy) −1,622 13,378

Page 24 of 25 · 494 trades